Dewey Kim

2.7k total citations · 1 hit paper
19 papers, 1.2k citations indexed

About

Dewey Kim is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Dewey Kim has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Dewey Kim's work include Cancer Genomics and Diagnostics (11 papers), Genomics and Rare Diseases (4 papers) and Advanced Breast Cancer Therapies (3 papers). Dewey Kim is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), Genomics and Rare Diseases (4 papers) and Advanced Breast Cancer Therapies (3 papers). Dewey Kim collaborates with scholars based in United States, United Kingdom and Sweden. Dewey Kim's co-authors include Rachel Karchin, Ivana Božić, Bert Vogelstein, Tibor Antal, Martin A. Nowak, Hisashi Ohtsuki, Sining Chen, Kenneth W. Kinzler, Hannah Carter and Mark Diekhans and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Dewey Kim

19 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Accumulation of driver and passenger mutations during tumor progression

2010 565 citations Ivana Božić, Tibor Antal et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dewey Kim United States	12	604	463	395	293	232	19	1.2k
Atsushi Niida Japan	18	1.0k 1.7×	387 0.8×	361 0.9×	155 0.5×	144 0.6×	42	1.5k
Doris P. Tabassum United States	5	521 0.9×	511 1.1×	462 1.2×	129 0.4×	112 0.5×	5	1.0k
Rosa‐Ana Risques Spain	7	629 1.0×	548 1.2×	262 0.7×	203 0.7×	195 0.8×	8	1.2k
Andrea Richardson United States	9	646 1.1×	439 0.9×	849 2.1×	156 0.5×	138 0.6×	12	1.4k
Renaud Grépin France	16	601 1.0×	278 0.6×	278 0.7×	61 0.2×	154 0.7×	26	917
Nnennaya Kanu United Kingdom	18	1.0k 1.7×	621 1.3×	815 2.1×	120 0.4×	354 1.5×	32	1.8k
Amit G. Deshwar Canada	11	541 0.9×	480 1.0×	107 0.3×	157 0.5×	70 0.3×	14	764
Maaike P.G. Vreeswijk Netherlands	22	992 1.6×	363 0.8×	518 1.3×	649 2.2×	82 0.4×	50	1.7k
Sam Thompson United Kingdom	4	897 1.5×	525 1.1×	295 0.7×	173 0.6×	207 0.9×	7	1.3k

Countries citing papers authored by Dewey Kim

Since Specialization

Citations

This map shows the geographic impact of Dewey Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dewey Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dewey Kim more than expected).

Fields of papers citing papers by Dewey Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dewey Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dewey Kim. The network helps show where Dewey Kim may publish in the future.

Co-authorship network of co-authors of Dewey Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Dewey Kim. A scholar is included among the top collaborators of Dewey Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dewey Kim. Dewey Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Lipsyc-Sharf, Marla, Esha Jain, Laura C. Collins, et al.. (2023). Genomics of ERBB2-Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus Trastuzumab. JCO Precision Oncology. 7(7). e2300076–e2300076. 3 indexed citations

Lamba, Nayan, Daniel Cagney, Paul J. Catalano, et al.. (2023). A genomic score to predict local control among patients with brain metastases managed with radiation. Neuro-Oncology. 25(10). 1815–1827. 3 indexed citations

Cooper, Alissa J., Yoshihisa Kobayashi, Dewey Kim, et al.. (2020). Identification of a RAS-activating TMEM87A–RASGRF1 Fusion in an Exceptional Responder to Sunitinib with Non–Small Cell Lung Cancer. Clinical Cancer Research. 26(15). 4072–4079. 14 indexed citations

Painter, Corrie, Esha Jain, Brett N. Tomson, et al.. (2020). The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research. Nature Medicine. 26(2). 181–187. 187 indexed citations

Cohen, Ofir, Pingping Mao, Utthara Nayar, et al.. (2020). Abstract GS2-02: Acquired activating mutations in RTKs confer endocrine resistance in ER+ metastatic breast cancer through ER-reprogramming, MAPK signaling, and an induced stem-like cell state. Cancer Research. 80(4_Supplement). GS2–2. 1 indexed citations

Buendia-Buendia, Jorge E., Ofir Cohen, Dewey Kim, et al.. (2019). Characterization of mutational processes in ER+ metastatic breast cancer.. Journal of Clinical Oncology. 37(15_suppl). 1019–1019. 1 indexed citations

Waks, Adrienne G., Ofir Cohen, Bose Kochupurakkal, et al.. (2019). Reversion and non-reversion mechanisms of resistance (MoR) to PARP inhibitor (PARPi) or platinum chemotherapy (chemotx) in patients (pts) with BRCA1/2-mutant metastatic breast cancer (MBC).. Journal of Clinical Oncology. 37(15_suppl). 1085–1085. 2 indexed citations

Wander, Seth A., Ofir Cohen, Gabriela N. Johnson, et al.. (2018). Whole exome sequencing (WES) in hormone-receptor positive (HR+) metastatic breast cancer (MBC) to identify mediators of resistance to cyclin-dependent kinase 4/6 inhibitors (CDK4/6i).. Journal of Clinical Oncology. 36(15_suppl). 12016–12016. 11 indexed citations

Barroso‐Sousa, Romualdo, Esha Jain, Dewey Kim, et al.. (2018). Determinants of high tumor mutational burden (TMB) and mutational signatures in breast cancer.. Journal of Clinical Oncology. 36(15_suppl). 1010–1010. 12 indexed citations

10.

Jaffe, Andrew E., Ran Tao, Alexis L. Norris, et al.. (2017). qSVA framework for RNA quality correction in differential expression analysis. Proceedings of the National Academy of Sciences. 114(27). 7130–7135. 59 indexed citations

11.

Wagle, Nikhil, Corrie Painter, Michael Dunphy, et al.. (2017). The Metastatic Breast Cancer (MBC) project: Accelerating translational research through direct patient engagement.. Journal of Clinical Oncology. 35(15_suppl). 1076–1076. 19 indexed citations

12.

Turner, Tychele N., Christopher Douville, Dewey Kim, et al.. (2015). Proteins linked to autosomal dominant and autosomal recessive disorders harbor characteristic rare missense mutation distribution patterns. Human Molecular Genetics. 24(21). 5995–6002. 31 indexed citations

13.

Niknafs, Noushin, Dewey Kim, Mark Diekhans, et al.. (2013). MuPIT interactive: webserver for mapping variant positions to annotated, interactive 3D structures. Human Genetics. 132(11). 1235–1243. 41 indexed citations

14.

Schaeffer, David J., et al.. (2013). The effect of ‘allergenic’ and ‘nonallergenic’ antibiotics on dog keratinocyte viability in vitro. Veterinary Dermatology. 24(5). 501–501. 3 indexed citations

15.

Jiao, Xiang, Laura D. Wood, Siân Jones, et al.. (2012). Somatic mutations in the notch, NF‐KB, PIK3CA, and hedgehog pathways in human breast cancers. Genes Chromosomes and Cancer. 51(5). 480–489. 59 indexed citations

16.

Wong, Wing Chung, Dewey Kim, Hannah Carter, et al.. (2011). CHASM and SNVBox: toolkit for detecting biologically important single nucleotide mutations in cancer. Bioinformatics. 27(15). 2147–2148. 85 indexed citations

17.

Peterson, Quinn P., Danny Hsu, Chris J. Novotny, et al.. (2010). Discovery and Canine Preclinical Assessment of a Nontoxic Procaspase-3–Activating Compound. Cancer Research. 70(18). 7232–7241. 51 indexed citations

18.

Božić, Ivana, Tibor Antal, Hisashi Ohtsuki, et al.. (2010). Accumulation of driver and passenger mutations during tumor progression. Proceedings of the National Academy of Sciences. 107(43). 18545–18550. 565 indexed citations breakdown →

19.

Kim, Dewey, Yoon Rhee, Denise Rhodes, et al.. (2005). Directed Evolution and Identification of Control Regions of ColE1 Plasmid Replication Origins Using Only Nucleotide Deletions. Journal of Molecular Biology. 351(4). 763–775. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact